Ultrasound In Cancer Research Group
Overview
Chemotherapy is the most extensively used treatment in the fight against malignant neoplasms. Unfortunately, chemotherapy use is plagued with numerous side effects. These side effects are caused primarily because of the non-specific nature of the treatment as the drug is capable of killing normal and cancerous cells alike. Several drug delivery systems have been investigated to reduce these side effects by encapsulating the chemotherapeutic agent in a nano-sized carrier until it reaches the tumor site. These carriers include solid nanoparticles, micelles, liposomes and e-liposomes. Once the nanoparticle reaches the desired location, ultrasound is applied to release the chemotherapy drug directly to the cancer site, thus avoiding any interaction with the healthy cells in the body. This minimizes the adverse side effects of chemotherapy.
Our lab would like to acknowledge funding from AUS Faculty Research Grants (both FRGs and eFRGs), Patient’s Friends Committee-Sharjah, AlJalila Foundation, Al Qasimi Foundation, the Technology Innovation Pioneer-Healthcare (TIP) Program, Takamul, Sheikh Hamdan Award for Medical Sciences, Friends of Cancer Patients (FoCP) and the Dana Gas Endowed Chair for Chemical Engineering.
